secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2023-01-20T23:59:59+00:00
Accession:  0001493152-23-002034
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics reduces executive salaries by 20%, terminates COO Shishir Sinha and CSO Wajdi Abdul-Ahad
--------------------------------------------------------------------------------

- Board approved 20% temporary base salary reduction for all executive officers, including CEO, CFO, President, COO, and CMO, effective immediately.
- COO Shishir Sinha terminated effective Feb 16, 2023; President Amy Broidrick's title becomes President, Chief Strategy and Operating Officer.
- Non-executive director annual cash compensation reduced by 20%.
- VP and Chief Scientific Officer Wajdi Abdul-Ahad position eliminated, along with several other non-executive roles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315223002034/0001493152-23-002034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315223002034/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-002034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer